Introduction {#sec1}
============

Infection with *Helicobacter pylori (H. pylori)* is common in humans and associated with socioeconomic status and living conditions in childhood.[@bib1] In developed countries, the prevalence of *H. pylori* infections has rapidly decreased in parallel to economic improvement over the past decades.[@bib2] This might be due to improved hygiene and sanitation, less salted food, and possibly increased use of antimicrobial agents.

Interestingly, as the prevalence of *H. pylori* has declined, there has been a rise in the prevalence of asthma and allergic diseases (e.g., hay fever and atopy) in developed countries.[@bib3], [@bib4], [@bib5] Tobacco smoking, air pollution, allergens, microbial infection, and obesity are among the potentially attributable exposures that may cause the increase of asthma and allergic diseases.[@bib6], [@bib7] As an indigenous microbiota, the decrease of *H. pylori* has been postulated to play a role in this increase.[@bib8] There have been quite a few epidemiologic studies examining the association between *H. pylori* and asthma and allergic diseases. The results, however, are largely controversial.[@bib9]

Parallel to the decrease in *H. pylori* infections, there has been a global increase of obesity during the past decades.[@bib10], [@bib11] Obesity is associated with chronic inflammation which may be involved in the allergic response.[@bib12] A positive association between obesity and asthma and allergic diseases has been reported in many studies.[@bib13], [@bib14] Moreover, lack of *H. pylori* infection has been associated with obesity in accumulating studies.[@bib15], [@bib16] Thus, there could be an association between *H. pylori,* obesity, and asthma and allergic diseases, but so far this has not been studied. Whether lack of *H. pylori* infection leads to increased risk of asthma and allergic diseases and obesity, independent of each other, or the lack of *H. pylori* infection leads to increased obesity and then increased risk of allergic diseases, as a part of the same causal pathway, is unknown. In this large population-based Norwegian study, we examined the association between *H. pylori* infection, obesity, and asthma and allergic diseases.

Methods {#sec2}
=======

Study design {#sec2.1}
------------

In this nested case-control study, data from the second survey of the Nord-Trøndelag Health Study (HUNT2) was used.[@bib17] In HUNT2, performed in 1995--1997, all residents of Nord-Trøndelag County aged 20 years and older were invited to answer questionnaires and interviews, participate in clinical examinations, and contribute with biological material. Among 65,237 participants in HUNT2 (69.5% of invited), serum from 10,005 randomly selected individuals were tested for *H. pylori.*

Study outcome {#sec2.2}
-------------

### Asthma and allergy {#sec2.2.1}

Asthma and allergy were assessed through self-reported questionnaires in HUNT2. Asthma was defined as present if the participants reported to have or have had asthma (ever), or if they reported to use or have used asthma medication (definition I). To avoid misclassification with chronic obstructive pulmonary disease (COPD) due to tobacco smoking, we also defined asthma as for definition I, but excluding participants that had smoked for more than 10 years (definition II). The participants also reported age of onset of asthma. Allergic rhinitis was defined as present if the participants reported to have hay fever or nasal allergy.

Main exposures {#sec2.3}
--------------

### H. pylori {#sec2.3.1}

Serological status of *H. pylori* IgG antibodies was analysed using the commercially available enzyme immunoassay Pylorisert EIA-IgG (Orion Diagnostica, Espoo, Finland) at Levanger Hospital, Norway. Assay for detection of *H. pylori* was performed in 1998. The cut-off level used for a positive *H. pylori* IgG was ≥300 U.[@bib18]

### General obesity and abdominal obesity {#sec2.3.2}

Trained personnel at the screening stations objectively measured height, weight, and waist circumference during HUNT2. Body mass index (BMI) was calculated by dividing weight in kilograms by height in meters squared (kg/m^2^) for estimation of general obesity. According to the World Health Organization\'s definitions, obesity was defined as BMI ≥30 and abdominal obesity as waist circumference ≥86 ​cm in women and ≥96 ​cm in men.

Other factors {#sec2.4}
-------------

The following factors were selected *a priori* and included in the analyses: sex, age, tobacco smoking, alcohol drinking (monthly frequency of drinking), physical activity (reported hours of physical activity \[light and hard\] per week in the last year), highest completed education, and family history of asthma and allergy. Except from sex and age, all factors were assessed through self-reported questionnaires. Family history of asthma or allergic rhinitis was reported on first degree relatives (parents, siblings, and children).

Statistical analysis {#sec2.5}
--------------------

Logistic regression was used to assess odds ratios (ORs) and 95% confidence intervals (CIs) for the associations between *H. pylori*, obesity, and asthma and allergy. Separate analyses were performed stratified for waist circumference categories based on the sex-specific intervals: \<75, ≥75 to \<86, and ≥86 for women; and \<88, ≥88 to \<96, and ≥96 for men. The fully adjusted analyses were performed with age as a continuous variable, while the other variables were categorized. Tobacco smoking was categorized as never, occasional, and daily. Alcohol drinking was categorized as never, infrequent (once a week or less), and frequent (more than once a week). Physical activity was categorized as inactive (no activity or less than one hour light activity a week), moderately active (1--2 hours light activity or less than 1 hour hard activity a week), and highly active (at least 3 hours light activity or at least 1 hour hard activity a week). Completed education was categorized as primary school, high school, and college/university. In order to entangle the complex relations between *H. pylori,* obesity and asthma and allergies, we performed a mediation analysis to estimate the indirect effect of obesity relative to the total effect of *H. pylori* on the outcome of interest. The SAS 9.4 for Window was applied for data management, descriptive statistical analysis and logistic regression. All statistical analysis were two sides with significant level at 0.05.

Ethical approval {#sec2.6}
----------------

The study has ethical approval through the Regional Committee for Medical and Health Research Ethics, Central Norway (2012/1878). In HUNT, all participants gave written informed consent when participating, stating that their data could be used in future medical research.

Results {#sec3}
=======

Characteristics {#sec3.1}
---------------

In the study population, the mean age was 50 years, 54% were women, and 31% were *H. pylori* positive ([Table 1](#tbl1){ref-type="table"}). The mean BMI was 26.4 ​kg/m^2^ (men:26.4; women; 26.3, respectively) and the mean waist circumference was 86.6 ​cm (men: 92.3; women: 81.6, respectively). Ever having had asthma was reported by 10.4% and after excluding those smoking \>10 years, the figure was 5.7%. Hay fever or nasal allergies were reported by 15.1% and allergic rhinitis (including use of anti-allergy medication) were present in 16.2%. In total, 26.5% of the 10,005 participants had asthma or an allergic disease.Table 1Basic characteristics of the randomly selected 10005 HUNT2 participants.Table 1TotalAsthmaHay fever or nasal allergiesAllergic rhinitisAsthma or allergic rhinitisDefinition IDefinition IITotalN%N%N%N%N%N%10005100104110.405695.69150715.06162016.19265526.54**Sex** Women541454.1157655.3333458.7088258.5395158.70148856.05 Men459145.8946544.6723541.3062541.4766941.30116743.95**Age** Mean (SD)50.11 (16.78)50.11 (17.51)46.31 (18.81)46.30 (16.08)46.54 (16.11)49.03 (16.97) Median (IQR)48.80 (27.00)49.40 (29.30)44.00 (31.30)43.90 (23.70)44.30 (24.05)47.70 (27.20) \<40316631.6433932.5625144.1161040.4864239.6392534.84 40-204620.4518918.168715.2931721.0434221.1152619.81 50-179617.9516515.857413.0124216.0627016.6743916.53 ≥60299329.9234833.4315727.5933822.4336622.5976528.81 Missing40.04***H. pylori* IgG** Negative692469.2171168.3041873.46112574.65120174.14185430.17 Positive308130.7933031.7015126.5438225.3541925.8680169.83**Body mass index** Mean (SD)26.36 (4.06)27.19 (4.51)27.01 (4.40)26.32 (4.15)26.39 (4.15)26.76 (4.31) Median (IQR)25.80 (5.00)26.50 (6.00)26.45 (6.10)25.80 (5.10)25.90 (5.20)26.20 (5.40) \<202732.73222.13142.47412.73442.73642.42 20-366636.6431330.2417731.2756037.3159436.8088733.57 25-436243.6044042.5123741.8765143.3770143.43114943.49 ≥30165616.5526025.1213824.3824916.5927517.0454220.51 Missing480.48**Waist circumference (cm)** Mean (SD)86.56 (11.86)89.25 (12.95)87.71 (12.47)85.85 (12.10)86.00 (12.10)87.64 (12.56) Median (IQR)86.00 (16.00)89.00 (18.00)87.00 (18.00)85.00 (16.00)86.00 (16.00)87.00 (18.00) Women\<75; Men\<88309530.9325324.5615627.7647431.8349931.1773928.14 75 ​≤ ​Women \<86; 88 ​≤ ​Men\<96349334.9131530.5818032.0353535.9357535.9288533.70 Women≥86; Men≥96330333.0146244.8522640.2148032.2452732.92100238.16 Missing1141.14**Tobacco smoking** No smoking411241.1038036.5038066.7870346.6574245.80104839.47 Smoking occasionally305730.5535534.1014024.6045229.9948830.1282230.96 Smoking daily283128.3030629.39498.6135223.3639024.0778529.57 Missing50.05**Alcohol drinking** Never237323.7227626.5114525.4837925.1540024.6966425.01 Infrequent457245.7045443.6125945.5272448.0477647.90121145.61 Frequent139913.9814013.455810.1920813.8022613.9536113.60 Missing166116.60**Physical activity** Inactive170917.0819518.738314.5922414.8624915.3746417.48 Moderately active295429.5329928.7216529.0050333.3853332.9082230.96 Highly active423442.3242841.1125745.1767844.9972344.63111141.85 Missing110811.07**Education** Primary school324132.3936334.8715827.7741727.6745027.7885932.35 High school319131.8932230.9316929.7045730.3350030.8682931.22 College/university309530.9329728.5320936.7358138.5561037.6583831.56 Missing4784.78**Family history of asthma** No796379.5963661.1029952.5559939.75102663.33180567.98 Yes203820.3740538.9027047.4590860.2559436.6785032.02 Missing40.04**Family history of allergic rhinitis** No692769.2457755.4334760.9894562.7167041.36141153.15 Yes307430.7246444.5722239.0256237.2995058.64124446.85 Missing40.04[^1][^2][^3][^4][^5]

Associations {#sec3.2}
------------

*H. pylori* infection was not associated with asthma or allergic diseases in general ([Table 2](#tbl2){ref-type="table"}), neither using the basic model, adjusting for sex and age, nor using the full model, also adjusting for BMI, tobacco smoking, alcohol drinking, physical activity, education, and family history of asthma and allergic diseases.Table 2Odds ratios (ORs) and 95% confidence intervals (CIs) of *H. pylori* infection relative to asthma and allergy.Table 2*H. pylori* infectionNegativePositive[d](#tbl2fnd){ref-type="table-fn"}Basic model[e](#tbl2fne){ref-type="table-fn"}Full modelNNOR (95% CI)OR (95% CI)[a](#tbl2fna){ref-type="table-fn"}Asthma (definition I)7113301.01 (0.87,1.17)1.00 (0.86,1.17) Asthma (onset at age\<18)287820.92 (0.70,1.20)0.93 (0.71,1.22) Asthma (onset at age≥18)2281411.07 (0.85,1.34)1.08 (0.85,1.36)[b](#tbl2fnb){ref-type="table-fn"}Asthma (definition II)4181510.90 (0.73,1.11)0.94 (0.76,1.16)Hay fever or nasal allergies11253820.91 (0.79,1.04)0.93 (0.81,1.07)[c](#tbl2fnc){ref-type="table-fn"}Allergic rhinitis12014190.93 (0.81,1.06)0.95 (0.83,1.09)Asthma or allergic rhinitis18548011.02 (0.92,1.13)1.03 (0.92,1.14)[^6][^7][^8][^9][^10]

Effect modification analysis {#sec3.3}
----------------------------

However, when stratifying for waist circumference, *H. pylori* infection was associated with asthma and allergy in individuals with abdominal obesity (waist circumference ≥86 ​cm in women and ≥96 ​cm in men) ([Table 3](#tbl3){ref-type="table"}). In abdominal obesity, *H. pylori* infection was associated with a 40% reduced odds of asthma (definition I) with onset below 18 years of age (fully adjusted OR 0.61, 95% CI 0.37--0.99). *H. pylori* infection in abdominal obesity was not associated with asthma (definition I) with onset above 18 years of age (fully adjusted OR 0.98, 95% CI 0.71--1.35). Excluding those smoking for more than 10 years (definition II), *H. pylori* infection in abdominal obesity was associated with a 30% reduced odds of asthma (fully adjusted OR 0.70, 95% CI 0.50--0.97). *H. pylori* infection in abdominal obesity was also associated with a 25% reduced odds of hay fever or nasal allergies (fully adjusted OR 0.75, 95% CI 0.59--0.95).Table 3Odds ratios (ORs) and 95% confidence intervals (CIs) of *H. pylori* infection relative to asthma and allergy, stratified by waist circumference.Table 3Waist circumference (cm): women\<75; men\<88Waist circumference (cm): 75 ≤ women\<86; 88 ≤ men\<96Waist circumference (cm): women≥86; men≥96*H. pylori* infection*H. pylori* infection*H. pylori* infectionNegativePositiveBasic model[d](#tbl3fn4){ref-type="table-fn"}Full ModelNegativePositiveBasic model[d](#tbl3fn4){ref-type="table-fn"}Full ModelNegativePositiveBasic model[d](#tbl3fn4){ref-type="table-fn"}Full ModelNNOR (95%CI)OR (95%CI)NNOR (95%CI)OR (95%CI)NNOR (95%CI)OR (95%CI)Asthma (definition I)[a](#tbl3fn1){ref-type="table-fn"}193600.97 (0.70,1.34)0.93 (0.67,1.30)2131021.16 (0.90,1.52)1.17 (0.89,1.53)2971650.91 (0.73,1.14)0.92 (0.73,1,15) Asthma (onset at age\<18)102240.97 (0.60,1.57)0.97 (0.59,1.59)87311.19 (0.77,1.85)1.24 (0.77,1.94)90240.58 (0.36,0.93)[∗](#tbl3fnlowast){ref-type="table-fn"}0.61 (0.37,0.99)[∗](#tbl3fnlowast){ref-type="table-fn"} Asthma (onset at age≥18)37251.55 (0.89,2.70)1.46 (0.83,2.57)67361.02 (0.66,1.57)1.00 (0.64,1.55)119800.99 (0.73,1.35)0.98 (0.71,1.35)Asthma (definition II)[b](#tbl3fn2){ref-type="table-fn"}125311.00 (0.65,1.54)1.05 (0.67,1.63)127531.12 (0.79,1.59)1.23 (0.85,1.77)161650.69 (0.50,0.94)[∗](#tbl3fnlowast){ref-type="table-fn"}0.70 (0.50,0.97)[∗](#tbl3fnlowast){ref-type="table-fn"}Hay fever or nasal allergies378960.97 (0.75,1.27)0.98 (0.74,1.29)3881471.07 (0.86,1.33)1.09 (0.86,1.37)3461340.72 (0.57,0.91)[∗](#tbl3fnlowast){ref-type="table-fn"}0.75 (0.59,0.95)[∗](#tbl3fnlowast){ref-type="table-fn"}Allergic rhinitis[c](#tbl3fn3){ref-type="table-fn"}3991000.96 (0.74,1.25)0.97 (0.74,1.27)4171581.06 (0.85,1.31)1.07 (0.86,1.34)3721550.77 (0.62,0.96)[∗](#tbl3fnlowast){ref-type="table-fn"}0.80 (0.64,1.01)Asthma or allergic rhinitis5711680.99 (0.80,1.223)0.99 (0.79,1.23)6172681.09 (0.91,1.30)1.10 (0.92,1.32)6443580.96 (0.81,1.13)0.98 (0.83, 1.16)[^11][^12][^13][^14][^15]

Discussion {#sec4}
==========

In the present study we found no association between *H. pylori* infection and asthma or allergic diseases in general. However, *H. pylori* infection was associated with a reduced risk of asthma and allergy in individuals with abdominal obesity, suggesting a possible causal pathway from reduced *H. pylori* infections through obesity to increased asthma and allergy.

The strengths of this study include the population-based design, large sample size, and random selection of participants where *H. pylori* status was assessed, reducing the risk of selection bias and chance findings. In addition, the HUNT study assessed a number of high quality variables that made adjustments for important confounders possible. The objective measurements of BMI and waist circumference are of great importance when assessing obesity. One weakness in this study is the self-reported asthma and allergy. This might introduce misclassification, mainly towards COPD. This is partly avoided by using a definition of asthma excluding participants that had smoked for more than 10 years (definition II) and stratified asthma with onset below 18 years of age (childhood asthma). Another weakness is the lack of data on cagA status, which has been regarded as an important factor in *H. pylori* infection that is negatively associated with asthma and allergy.[@bib19] As this is an observational study, causal associations cannot be claimed based on concurrent measurements of outcomes, exposures, and confounders.

A potential inverse relationship between *H. pylori* and asthma and allergy has been widely reported, although the results are controversial.[@bib20], [@bib21], [@bib22], [@bib23], [@bib24], [@bib25] In the largest meta-analysis including 19 studies,[@bib9] an inverse association between *H. pylori* and asthma was demonstrated based on nine cross-sectional studies (pooled OR 0.84, 95% CI 0.74--0.96), but the pooled OR was not statistically significant in seven case-control studies (pooled OR 0.82, 95% CI 0.53--1.27) or three prospective cohort studies (pooled OR 0.82, 95% CI 0.53--1.27). Interestingly, the meta-analysis showed an inverse association in children (pooled OR 0.81, 95% CI 0.72--0.91) but not in adults (pooled OR 0.88, 95% CI 0.71--1.08), which is partially consistent with our results. The benefit of *H. pylori* in early life has been observed in quite a few studies,[@bib20], [@bib21], [@bib22], [@bib26], [@bib27] but at a late-in-life cost (e.g., *H. pylori* is a risk factor of peptic ulcer disease and stomach cancer).[@bib28] However, in the present study, such an inverse association were only identified in abdominally obese persons who had asthma or allergic rhinitis in their early life. This result may indicate an intriguing and complex relationship between *H. pylori*, obesity, and asthma and allergy.

A possible inverse relationship between exposure to *H. pylori* and the occurrence of obesity has been addressed as well,[@bib15], [@bib29], [@bib30], [@bib31] although the results are still controversial.[@bib32] Moreover, whether *H. pylori* infection plays a role only in childhood or adult adiposity is unclear. As both *H. pylori* and obesity have been associated with asthma and allergic disease, the role of the two factors needs to be further clarified. Whether one factor is another factor\'s confounder, effect modifier or intermediate is unknown. In the present study, there was an association between *H. pylori* and asthma and allergic disease in abdominally obese participants, but this association disappeared in the non-abdominally obese population. This indicates that obesity may play a role as an effect modifier between *H. pylori* and asthma and allergy. As the analyses were based on cross-sectional data, potential obesity could be an intermediate in the pathway from *H. pylori* to asthma and allergy.

The underlying mechanisms between *H. pylori*, obesity, and asthma and allergy are plausible. *H. pylori* are one of the most common bacteria in humans, with prevalence rates of *H. pylori* in human populations ranging from 20 to 50%.[@bib33], [@bib34] In the past decades, infection with *H. pylori* substantially declined due to improved living conditions and increased use of antibiotics. Individuals exposed to *H. pylori* in early childhood are prone to have a decreased appetite and food intake due to defective signalling of appetite- and satiety-related hormones in the stomach, e.g., ghrelin and leptin.[@bib20], [@bib35] Hormone ghrelin exerts long-term appetite stimulating behaviour through its receptors in the hypothalamic paraventricular and arcuate nuclei.[@bib36], [@bib37] Decreased exposure to *H. pylori* results in increased ghrelin and downregulated gastric leptin in children and in adults, thus increasing appetite stimulating behaviour and then leading to obesity. Interestingly, ghrelin has been associated with abdominal adiposity through regulation of lipid storage in abdominal white adipose tissue[@bib38]; higher leptin levels has also been associated with abdominal obesity in quite a few studies.[@bib39], [@bib40] In addition, *H. pylori* could be an indicator for changes in the gut microbiome. It reflects the complex interaction between microbes and the immune system.[@bib41], [@bib42] When *H. pylori* are eradicated (other microbes will be influenced as well), the inner balance of microbes, appetite-related hormones, and the immune system will be broken, and then the person will become obese. The cytokines stimulated by chronic inflammation in the obese population will further trigger asthma and allergy. On the other hand, in obese persons, the cytokines may be supressed by infection with *H. pylori*. A protective association of *H. pylori* with asthma and allergic disease through obesity is plausible. This hypothesis aligns with the present study.

Another potential pathway is through Th1 and Th2 lymphocytes. A growing body of evidence indicates a preventive action of *H. pylori* to asthma and allergy probably through the gastric recruitment of regulatory T cells.[@bib43] It is well recognized that infections with *H. pylori* can trigger a Th1-mediated immune response.[@bib43] Activation of Th1 then suppresses the Th2 responses. The predominant activation of Th1 lymphocytes by *H. pylori* leads to the production of interferon gamma, interleukin 12, and tumor necrosis factor alpha in the stomach.[@bib44] Eradication of *H. pylori* will lead to inadequate Th1 response that might result in an overactive Th2 response with production of cytokines, including interleukins 4, 5, and 13, which are associated with the promotion of IgE and eosinophilic responses, and eventually allergies. The inverse association between *H. pylori* and asthma and allergic disease was first observed in 1989 with the "hygiene hypothesis".[@bib45] It was based on observations of declining prevalence of allergic rhinitis with increasing number of older siblings. It suggested a preventive effect of transmitted infections in early childhood from older siblings. Exposure to infectious agents might educate the immune system and provide protection against allergic rhinitis. However, how obesity plays a role in this pathway is unclear. As the benefit of *H. pylori* was only shown in the obese population, the present study might suggest that the immune system educated by infection with *H. pylori* may be more alert to asthma and allergy in those obese.

In conclusion, this large population-based study found reduced risk of asthma and allergy with *H. pylori* infection in individuals with abdominal obesity. This suggests a possible protective effect of *H. pylori* infection in the development of asthma and allergy and possibly a causal pathway from reduced *H. pylori* infections through obesity to increased asthma and allergy.
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[^1]: Asthma definition I: Asthma or medication for asthma.

[^2]: Asthma definition II: Definition I, excluding those smoking for more than 10 years.

[^3]: Allergic rhinitis: Hay fever or nasal allergies or use of anti-allergy medications.

[^4]: SD: standard deviation.

[^5]: IQR: interquartile range.

[^6]: Asthma definition I: Asthma or medication for asthma.

[^7]: Asthma definition II: Definition I, excluding those smoking for more than 10 years.

[^8]: Allergic rhinitis: Hay fever or nasal allergies or use of anti-allergy medications.

[^9]: Basic model: Adjusted for sex and age.

[^10]: Full model: Adjusted for sex, age, body mass index, tobacco smoking, alcohol drinking, physical activity, education, and family history of asthma or allergic rhinitis.

[^11]: Asthma definition I: Asthma or medication for asthma.

[^12]: Asthma definition II: Definition I, excluding those smoking for more than 10 years.

[^13]: Allergic rhinitis: Hay fever or nasal allergies or use of anti-allergy medications.

[^14]: Basic model: Adjusted for sex and age.

[^15]: p \< 0.05.
